<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Introduction</title></head><body><div><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:center"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by Universities Allied for Essential Medicines (UAEM) (AMR0021)</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Introduction</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The following paper was written by members of the public health advocacy group, Universities Allied for Essential Medicines (UAEM). As an organisation, it is our aim to advocate for the maximal public health impact of pharmaceutical products in order to fulfil the universal human right to health. This includes challenging political, legal and economic barriers preventing access to essential medicines (particularly to individuals and communities in developing countries), while calling for the development of pharmaceutical agents which respond to unmet public health needs. This includes products for neglected and tropical diseases, as well as new antibiotics and incremental advances on existing medicines which the pharmaceutical industry has so far failed to deliver. </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">We have focussed our submission on answering questions 3, 5 and 6 in the inquiries terms of reference as these most suited out expertise.</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Executive summary</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Antimicrobial resistance is being increasingly recognised as a serious global health threat, in Europe 50% of all hospital acquired infections are drug resistant. </span></li><ul type="circle" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Current market driven models of drug development are proving insufficient to meet this threat with less than 10% of new drugs currently being researched using a novel mechanism of action</span></li><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">While it’s good that the government has developed a five-year AMR strategy it does not go far enough to provide a clear action plan to ameliorate the current problems</span></li></ul><li style="background-color:#ffffff; font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The cost-price linkage of pharmaceutical R&amp;D has significantly contributed to these trends, resulting in:</span></li><ul type="circle" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Prohibitive pricing of end-products of pharmaceutical innovation;</span></li><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Spiralling R&amp;D costs with a simultaneous decline in innovation;</span></li><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Emptying of the pharmaceutical R&amp;D pipeline;</span></li></ul><li style="background-color:#ffffff; font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The Global Framework on Research and Development was the key proposal of the 2012 CEWG report and would incentivise research into AMR by the following:</span></li><ul type="circle" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">“De-linking” of the cost of R&amp;D from the price of medications through a predictable financing mechanism from governmental sources</span></li><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Funding of R&amp;D targeted at global health priority areas including AMR and neglected areas of current research</span></li><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Management of intellectual property to ensure open knowledge sharing and improve further innovation from research.</span></li></ul><li style="background-color:#ffffff; font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">In addition to the Global R&amp;D framework the following approaches are encouraged in light of the changing context of pharmaceutical research with increased collaborative approaches between governmental and non-governmental actors</span></li><ul type="circle" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Courier New'; font-size:10pt; margin:0pt 0pt 0pt 65pt; padding-left:7pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">It is suggested that government funding is used to induce the formation of novel public-private partnerships called non-profit drug development corporations, proposed by Rudolph Juliano, along with the adoption of ethical publication and socially-responsible licensing practices by research entities</span></li></ul><li style="background-color:#ffffff; font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Policy approaches deemed less efficient in meeting the particular needs of AMR include the following included extended patent terms and direct tax credits.</span></li></ul><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not, how could this be rectified?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Resistance to antibiotics is increasingly being recognised as one of the most serious threats to health, not only in Europe, but worldwide. In the EU alone, half of all hospital acquired infections are drug resistant (European Academies Science Advisory Council 2007; Vicente et al. 2006), </span><span style="font-family:'Times New Roman'; font-size:11pt">leading to a 1.3 to 2 fold increase in deaths (Cosgrove &amp; Carmeli 2003). In the USA, conservative estimates have shown more than 23000 people die each year as a consequence of these infections (CDC, 2013). Antimicrobial resistance (AMR) also imposes a huge financial problem both to the NHS in the form of higher treatment costs and longer hospital stays, (Cosgrove 2006; Mauldin 2010; Okeke 2005; Roberts et al. 2009), and to household income, government tax revenues and national savings leading to a 1.6% decrease in gross domestic product (Smith et al. 2005). Antimicrobial resistance patterns have changed from being centred around MRSA and C. difficile, to gram negative organisms, which are the cause of more than half of all bacteraemias (Chief Medical Officer, 2013), widening the number of people affected by AMR.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Compounding the issue of increasing resistance to current antibiotics is a reduction in research in the quality and number of new antibiotics. </span><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:11pt">In 2009 </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">only two new antimicrobials were under development, both in primary stages, where failure rate is high (European Centre for Disease Prevention and Control and European Medicines Agency joint report. 2009</span><span style="font-family:'Times New Roman'; font-size:11pt">)</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. </span><span style="font-family:'Times New Roman'; font-size:11pt">Worldwide, a study in 2004 showed only 6 out of 506 drugs in development by 22 large companies were antimicrobials (Spellberg et al, 2009) and that many of the new drugs on the market were slight modifications of existing formulations. In 2008, a study revealed only 15 out of 167 medicines under development had a novel mechanism of action (Brain, T. 2009). </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">AMR has been recognised, and attempts have been made to rectify this problem. Research initiatives have been funded by the UKCRC, BIS, and Defra, with more than £40 million invested, however despite these efforts AMR has continued to grow, and more progress is needed at a global and national level to have a significant impact. (Department of Health, 2013) This highlights a key area of failure of the current system of incentivising innovation.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">To tackle this problem, </span><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:11pt">the Government of the United Kingdom have developed a five year antimicrobial resistance strategy based largely on the Chief Medical Officers report (Chief Medical Officer, 2013), and the 2011 EU AMR strategic plan (European Commission, 2011). </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">We applaud the government's effort to put together a report detailing its strategy to tackle antimicrobial resistance. The strategy outlines seven key areas for future action based on the 2011 EU AMR strategic action plan, however it falls short of providing a clear action plan on how it aims to take forward these recommendations in terms of policy setting or research funding.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">We present options reported in the literature to address the problems of AMR and the emptying R&amp;D pipeline including an overview of their respective merits and limitations.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives? </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What are the strengths and weaknesses of the Government’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">We shall focus on key area 4: developing new drugs, treatments and diagnostics, as whilst the other areas of intervention are important factors in slowing the development of antimicrobial resistance, none can halt it, and so the only way to be sure we’ll continue to have effective drugs in the future is to work on developing new ones.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The policy options for stimulating antimicrobial research can be broadly divided into four categories;</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 60.55pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Pull - </span><span style="font-family:'Times New Roman'; font-size:11pt">Foster R&amp;D via financial rewards, e.g. monetary prizes for delivering specific results</span></p><p style="margin:0pt 0pt 0pt 60.55pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Push - Reducing the cost of R&amp;D</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 60.55pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Lego-regulatory - similar to pull mechanisms, but use the market to determine reward size</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 60.55pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">d)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Hybrid - a mixture of pull/push mechanisms</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Pull incentives</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The proposals of The Consultative Expert Working Group on R&amp;D: Financing and Coordination (CEWG) (WHO, 2012) report are discussed below, including the pull mechanisms and cross-border initiatives endorsed by the report authors </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 12.5pt; padding-left:5.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">CEWG report</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The CEWG was commissioned by the World Health Assembly in 2010 to look into methods to stimulate R&amp;D financing and coordination in sectors failed my traditional market forces. The CEWG report evaluated several proposals for reform in R&amp;D structures including tax breaks for companies and orphan drug legislation. Criticisms of these approaches are touched upon in other sections of this report. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The key proposals the CEWG report makes relate to the “de-linking” of R&amp;D costs from the cost of the final product thereby shielding research agendas from the demands of profitability, instead allowing a more complete focus for R&amp;D based on the needs of populations. Several mechanisms promoted de-linking and were highlighted as more effective by the report authors. The proposal deemed most effective in the report was the Global Framework on Research and Development. The following discussion will focus on this framework and its particular relevance to a coordinated approach to the problem of AMR. </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Global Framework on Research and Development</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Objectives</span><br /><span style="font-family:'Times New Roman'; font-size:11pt">This proposal, endorsed by the CEWG report, sought negotiations under the WHO for a new treaty between member states for Health R&amp;D. As stated in the CEWG report the treaty seeks to promote “a sustainable model of medical innovation”. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="12" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Elements</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">To address this goal the elements of a proposed treaty would include the following:</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Coordination mechanisms - development of appropriate R&amp;D networks to facilitate the efficient transfer of knowledge</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Financing - ensuring a predictable funding source, mainly from a defined contribution from different governments. Criteria for financing should incorporate:</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D incentives that further the de-linking of R&amp;D costs from the costs of the final products</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D targeted at specific global health priority products such as antibiotics as well as the special health needs of currently neglected developing countries</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Management of R&amp;D outcomes, assets and intellectual property rights - ensuring the open sharing of knowledge and the products of R&amp;D to protect the public interest and encourage further innovation potential.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="13" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Financing</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">To produce sustainable financing for R&amp;D under the treaty, it is proposed that WHO member state governments contribute a fixed proportion of GDP. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The amount specified would be determined based on a country’s level of development and managed under a transparent system. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Supplementary financing from other sources would also be considered under the treaty. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">To generate their respective contributions it is proposed member states use mandatory levies on certain products or other tax-based systems,</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Examples cited including a financial transactions tax and smoking taxation. </span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Coordination</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">To guide and supervise the funding of R&amp;D proposals under the auspices of the treaty an R&amp;D architecture would be designed to guide priority setting and perform a research needs assessment.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The components of a proposed global R&amp;D architecture are:</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Needs assessment - identify specific health problems at each population level and existing healthcare resources available in each needs domain. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Priority setting - areas of greatest need or in areas where current R&amp;D activity is low or non-existent prioritised with funding.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D funding structure - determine the specific incentives used to fund R&amp;D. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="15" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Incentives</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Delinking is the main approach the treaty promotes with incentives</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The treaty is flexible in incentives used to fund R&amp;D, certain projects may benefit from targeted prize funds or grants whilst others may be better developed by socially responsible licensing policies. </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Other guiding principles in addition to delinking include</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Funding should be provided for all aspects of R&amp;D, including the relevant clinical trials needed for formal market authorisation.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Intellectual property management - treaty funded R&amp;D research outcomes should not be monopolized by IP patent protections. This is to encourage maximum further innovation efforts from each R&amp;D product. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Monitoring - a key principle is the development of coordinated R&amp;D efforts at each level of government and research. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="16" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Relevance to UK AMR strategy</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The UK government should take steps to promote the adoption of the Global R&amp;D treaty under the WHO as part of its AMR strategy. The treaty addresses the structural problems that currently restrict the drug development pipeline including:</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Market failure - the current patent driven innovation system, as discussed in the introduction, fails to encourage R&amp;D into antibiotic agents</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Co-ordination - the Global R&amp;D treaty enshrines coordinated research approaches as one of the core principles in its recommendations. Other aspects of the treaty help foster coordinated R&amp;D approaches:</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Intellectual property management - R&amp;D funded under the treaty will not be monopolised using patent incentives, this eases further research into newly developed therapeutic agents by follow-on research.</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Monitoring systems - the treaty encourages review of R&amp;D funded projects </span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(3)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Needs assessment and Priority-setting - by identifying key areas for research based on population level health needs the treaty encourages a focus on international health priorities such as AMR. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Affordability - The current paradigm drug development leads to expensive therapies being brought to market. Newer antibiotics will be widely used and pose significant financial burdens on existing healthcare systems. Adopting the Global R&amp;D treaty will reduce the costs of antibiotics developed by R&amp;D funded by the treaty.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="17" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">This call for a systematic and transparent global approach to R&amp;D will improve prioritization, coordination and sustainable financing of R&amp;D helping significantly in promoting access to research outcomes and shifting the research agenda towards significant disease entities in terms of the global burden of disease. </span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="18" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">The next steps in adopting a Global R&amp;D treaty</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Discussions promoting adoption of a global R&amp;D treaty have been ongoing for 14 years now with significant input from both governmental, private-sector and civil society actors (Kidell-Monroe and Helene Iversen et al., 2013). </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">An open-ended WHO meeting convened on November 2012 to follow up on the CEWG report recommendations drafted a resolution for the World Health Assembly to postpone discussion on the main report recommendations, specifically the R&amp;D treaty, until 2016. (Love, 2013)</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">With debate postponed till 2016 it is imperative that the UK government reconsiders its position on the CEWG report in concordance with principles of Human Rights and in face of the previously acknowledged urgent and unaddressed problems in health both local and global. </span><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="19" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Push Mechanisms</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt; text-align:justify; text-indent:18pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Direct funding of grants/fellowships &amp; Translational research</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The NIHR put together an AMR themed call as a result of the Chief Medical Officers 2011 Annual Report</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">It’s seen eight NIHR funding programmes put out calls for funding applications into research to collect data and develop solutions for key areas 1-3 in the governments AMR strategy. (NIHR 2013)</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">However to tackle key area 4 would require the government to provide a major increase in direct funding of antibiotic research through the MRC to the UKCRC Translational Infection Research Initiative.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="20" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Tax credits</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The UK already offers one of the most generous R&amp;D tax credit systems in the world</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">175% (under the SME scheme) or 130% (under the large company scheme) of qualifying expenditure on R&amp;D activities is deducted when calculating their profit for tax purposes (HMRC) cf. 13.5% in Belgium (WHO, 2010) </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Providing tax credits to private sector companies can be a double edged sword in stimulating R&amp;D funding. </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">d)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The criteria to qualify for the current tax credits require companies to be performing any R&amp;D with an aim to ‘advance science and technology’.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">e)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">This blanket use of tax credits has seen the cost to government increase from £89 million in 2000-2001 to £1.1 billion in 2010-2011, with the majority going to large companies.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">f)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Despite this the number of innovative medicines coming to the market has been falling</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Pharmaceutical companies increasingly put their focus on developing ‘me-too’ drugs that offer little to no clinical benefit</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">rather than the tax credits stimulating innovation they often simply boosting the profits of companies engaging in the R&amp;D.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">g)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">In order to stimulate innovation tax credits need to be directed at areas of R&amp;D where the market is failing, ie. AMR, and their ability to make an appreciable improvement to an existing product needs to be more thoroughly proven. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="21" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Product Development Partnerships (PDPs)</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">A type of public-private partnership, the PDP is a virtual non-profit organisation which outsources activities to partners in the academic, NGO, public and private sectors, using funding and other contributions from public and in-kind private sources (Grace, 2010).</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Multiple avenues of innovation are pursued simultaneously, with a portfolio of pharmaceutical R&amp;D projects managed by the PDP and consulted on by an independent committee of scientific experts.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Their main functions, then, are the following:</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Link expertise from different spheres;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Provide public funding;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Provide technical oversight;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iv)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Manage a portfolio of research projects.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">d)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">They operate with the objective of developing health products of a specific type (e.g. drugs or vaccines) and, in some cases, for a specific disease area.</span></p><ol start="22" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Non-profit Drug Development Corporations (NPDDCs)</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">This is a novel partnership model proposed by Rudolph Juliano (2013), in order to adapt the PDP model so that its benefits may be applied to R&amp;D outside of NTDs.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">The model he describes is as follows.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Partners from the academic, NGO and biopharmaceutical sectors form a joint venture virtual organisation (a ‘Board of Directors’, as shown in Figure 1), responsible for the management of a portfolio of research projects (in the same vein as PDPs), which may be outsourced to contract research organisations (CROs). CROs may also be partners.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">A governmental funding body sets the research agenda (according to public health need), and invites applications for grant funding from different, competing NPDDCs.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Applications will contain meticulous details as to the contributions of and division of labour between different partners, the share ownership and intellectual property arrangements concerning the resultant technology, as well as conventional research proposals concerning the line of inquiry to be pursued.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iv)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Contributions of partners need not necessarily be financial. Pharmaceutical companies, for example, could donate access to chemical databases or human resources on a </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">pro bono</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> basis, while universities could offer faculty research time (Juliano, 2013).</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">v)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Grant funding will be allocated on the strength of these applications.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><img src="data:image/png;base64,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" width="559" height="507" alt="https://lh3.googleusercontent.com/EZ7OW8dJhMlhR34uwhLWEA4abW5qL_1JFLBD7nMU40X1RJV9E5jN7jp08GorVnjBOOe2J8CYJ4_t5BmVrGA3DcJGSwbS46hxjL9AXInZGzOSEYzYCQATb4UlGQ" style="margin-left:16.02pt; margin-top:35.75pt; position:absolute; z-index:0" /><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Multiple NPDDCs may be recruited by government to pursue the same, or different, research goals in parallel.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol start="23" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Lego-regulatory mechanisms</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The amount of new molecular entities developed per $billion spend on R&amp;D has declined during the last half decade. This is speculated to be for numerous reasons, one being an increase in regulatory costs</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Three lego-regulatory mechanisms are mentioned in the CMO’s report</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Expediting regulatory review</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Extending patent terms</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Adjusting pricing or reimbursement procedures</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">A review of the current evidence of these three mechanisms shows that they have little potential for significant impact when addressing the market failures involved in development of novel antibiotics.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Market-based interventions will only have success were the market is an appropriate mechanism for delivery, where the incentives of the market match the needs of society.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Currently, pharmaceuticals are expensive because the price is linked to all preceding expenditure; are of consistently poor quality; and are not developed according to needs based priorities. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Considering the fact that pharmaceutical companies enter less profitable markets for strategic, rather than commercial concerns, brings into questions the efficacy of lego-regulatory mechanisms. (Moran, 2005)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="24" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Extending Patent terms</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Patents increase innovation only as measured by the number of patents issues. The effect of more stringent intellectual property laws has seen a dramatic increase in the number of patents issued. (Abrams, 2009)</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">While patents and patent terms have increased, the number of effective new drugs being developed (a far better measure of innovation) has not increased. Of 961 new drugs licensed from 1999-2008 only 2% of these were found to give a significant therapeutic advantage.(Anon, 2012) </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Specifically to antibiotics, while TRIPS has set 20 year patents as a global norm the number of new antibiotics has actually halved between the periods 1983-87 (16 antibiotics) and 1998-2002 (7 antibiotics) (Spellberg et al., 2004)</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Patent term extensions have been trialled in orphan drug legislation</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><img src="data:image/png;base64,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" width="602" height="359" alt="https://lh6.googleusercontent.com/wFJGG0q_zXGXglgDltnoE0NRf66xbDmCyB9a86gpiSD8Km0y4MIlgLtMCM2PT8ABrn1nISfVsBXXHbvPqrzYpuTu_glKJPAXoBjoq9j2K_BqSrbLckcc6ZtT_Q" style="margin-left:-0.1pt; margin-top:39.95pt; position:absolute; z-index:1" /><br /><span style="font-family:'Times New Roman'; font-size:11pt">More stringent criteria are required to assess Orphan medicinal product’s efficacy and cost/effectiveness to improve the clinical value and the affordability of products allowed onto the market (Joppi et al, 2013)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="25" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Expediting Regulatory Review</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Burdensome regulatory processes may disincentivise otherwise willing pharmaceutical companies from developing drugs for small markets. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Reducing the regulatory requirements may reduce the cost of entering the market. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">However, minimum regulatory requirements must be met to secure efficacious new developments. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Reducing the regulatory requirements results in more unsafe drugs being approved (Olson, 2008) </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">New regulatory measures should continue to be analysed</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The use of non-inferiority in clinical trials is a subject of fierce debate </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Proving safety and efficacy should be the fundamental goal </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">In cases where no effective treatment exists it could be argued a relatively toxic treatment may be better than nothing.</span></p><ol start="26" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Adjusting pricing or reimbursement</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Adjusting the price government pays for branded antibiotics would increase potential revenues thereby incentivising R&amp;D</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Pricing procedures could bring an added benefit when they are linked in some way to the therapeutic or social value of the drug. </span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Such an approach would be technically complex and expensive</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">In the UK, the government are moving from the Pharmaceutical Price Referencing System (PPRS) to Value-Based Pricing </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">d)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">PPRS is a voluntary agreement between the Department of Health and the pharmaceutical industry</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Under this agreement the industry has the freedom to set the price, but the government can regulate the amount of profit allowed to make through sales to the NHS.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">e)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Value-Based Pricing will involve setting the price according to certain cost-effectiveness measurements such as cost per Quality Adjusted Life Years gained.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">i)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">There will be proposed cost-effectiveness thresholds for any given drug.</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">ii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The government has proposed setting higher thresholds</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">for drugs treating diseases with a higher burden of illness (particularly those with unmet need);</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">for drugs that demonstrate an increase in therapeutic effectiveness;</span></p><p style="margin:0pt 0pt 0pt 72pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">(3)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">for drugs that demonstrate a ‘wider societal benefit’ (Department of Health, 2010)</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">iii)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Pharmaceutical companies will be free to propose a price, which NICE will then assess for cost-effectiveness. If the price is found to exceed cost-effectiveness, companies will be asked to provide robust evidence to justify a higher price.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="27" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Conclusion</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The Global R&amp;D treaty, if adopted, would produce a huge impact on public health and allow governmental actors to help tailor research agendas to the specific health needs of their populations and pressing global health concerns such as antimicrobial resistance. Signing onto a legal framework will ensure sustainable R&amp;D funding allied to public health needs and also improve the wider availability of the products of research. </span></p><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="28" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Times New Roman'; font-size:10pt; font-style:normal; font-variant:small-caps; font-weight:normal; margin:0pt 0pt 0pt 17.5pt; padding-left:0.5pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Recommendations for Parliament</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Support the efforts of the WHO to develop a Global R&amp;D Treaty</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Increase direct grant funding to the MRC UKCRC Translational Infection Research Initiative</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Put together a Non-profit Drug Development Corporation under the auspices of the Department of Business, Innovation &amp; Skills and the Department of Health to direct AMR research</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">d)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Adapt the R&amp;D tax credits system to promote true innovation and direct the research agenda</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">e)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Review medicines regulatory mechanisms, bearing in mind safety concerns</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:10pt">f)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Closely monitor the introduction of value based pricing of medicines with a view to ensuring cost effectiveness, transparency and its effect on stimulating R&amp;D</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">November 2013</span></p></div><br style="clear:both; mso-break-type:section-break; page-break-before:always" /><div><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Appendix1: Summary table of proposed mechanisms stimulating antimicrobial research. Green = Recommended, Red = Not Recommended</span><a name="_GoBack"></a><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><table cellspacing="0" cellpadding="0" style="border-collapse:collapse; margin-left:0pt"><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Proposal</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Advantages</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Disadvantages</span></p></td></tr><tr><td style="background-color:#a8d08d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Global R&amp;D treaty</span></p></td><td style="background-color:#a8d08d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">De-linking mechanism - the Global R&amp;D treaty offers an alternative financing approach that ‘de-links’ the cost of R&amp;D from the demands of profitability optimising the research agenda towards health need cf. economic need.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Co-ordination - the Global R&amp;D treaty enshrines coordinated research approaches as one of the core principles.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Intellectual property management - R&amp;D funded under the treaty will not be monopolised using patent incentives, this encourages innovation with follow-on research to further improve therapeutic efficacy of new medications developed. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Needs assessment and Priority-setting - by identifying key areas for research based on population level health needs the treaty encourages a focus on international health priorities such as AMR. </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Affordability - currently newly developed drug compounds are expensive when initially brought to market, adopting this approach will avoid this by facilitating at-cost pricing of newly developed therapeutic agents.</span></p></td><td style="background-color:#a8d08d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The Global R&amp;D treaty has not yet been implemented with further international support needed.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr><tr><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Direct Funding / Grants</span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Government directed research agenda</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Funds basic (pre-clinical) research, most neglected by industry</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Attractive to SMEs due to limited R&amp;D funding resources</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">MRC is experienced in performing world class translational research </span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Information asymmetry between funder and researcher - Research groups may have incentive to present research in the most positive light in order to maintain funding, and may lack motivation to continue development once push funding ends</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr><tr><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Tax Credits (as used currently in UK)</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Reduces R&amp;D costs to industry</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Expensive</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Doesn’t stimulate innovation</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Doesn’t allow government to direct research agenda</span></p></td></tr><tr><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Product Development Partnerships</span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Harness the inputs of diverse entities, allowing the optimal utilisation of their respective resources and unleashing otherwise untapped potential, including:</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Unprecedented up-scaling and commercialisation of novel academic discoveries using the capital and experience of private sector actors;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Navigation of new and unfamiliar markets by private sector actors, with the aid of field-experienced NGOs;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The partnership model allows for the development of in-roads for the training of the next generation of human resources in pharmaceutical R&amp;D (Grace, 2010).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Virtual administrative structure keeps overheads low (Munos, 2006).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Project focus allows for rapid decision-making unfettered by conflicting business interests (Munos, 2006; Juliano, 2013).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Outsourcing tasks to Contract Research Organisations (CROs) bypasses the need for out-of-pocket expenditure </span><span style="font-family:'Times New Roman'; font-size:11pt">on start-up capital, reducing costs (Hu et al, 2007).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Historically, PDPs have been able to operate on very small budgets compared with ‘big pharma’. For example, the cumulative spend by the Medicines for Malaria Venture between 2000 and 2005 was USD 100 million, 90% of which funded actual research (Munos, 2006).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Builds research capacity in developing countries (Juliano, 2013).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Some PDPs offer private sector actors intellectual property over the results of their contributions in order to secure their input, with the opportunity of developing more commercial applications for new technologies (Pugatch et al, 2012). </span><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The model has so far failed to demonstrate its sustainability, with the majority of projects coming from shelved pharmaceutical company projects (Munos, 2006).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Continued reliance on philanthropic funding is unsustainable (CEWG, 2012).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The PDP model has yet to be applied to an area other than neglected and tropical diseases (Munos, 2006).</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr><tr><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Non-profit Drug Development Corporations (NPDDCs)</span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Corporate entities may be induced to join these partnerships with the prospect of different income streams in the form of government purchases, as well as royalties from licensing of products to manufacturers of generics.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Government may set the research agenda, encouraging drug development to meet public health needs.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Financial reward for investment by government allows for the refilling of public coffers, contrasting with tax credits which constitute a one-way flow of public finances.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">NPDDC business model is in line with ethos of BIS’ Catapult initiative, in developing a deeper relationship between academia and industry.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Academic partners stand to make greater financial returns on the work that they contribute to commercially-viable </span><span style="font-family:'Times New Roman'; font-size:11pt">knowledge.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Fostering a deep relationship between academia and industry allows for the development of graduate career prospects.</span></p></td><td style="background-color:#93c47d; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">As yet untested as a business model</span></p></td></tr><tr><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Extending Patent Terms</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Monopoly power offered to pharmaceutical companies offers a financial reward for developing new pharmaceuticals.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Patent term extensions would be relatively easy to implement, because patenting systems are already in place.</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The patent system is liable to abuse, because it provides </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">“an incentive to game the system by artificially creating monopolistic market conditions.”</span><span style="font-family:'Times New Roman'; font-size:11pt">  (Simoens, 2011)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The patent system is not proven as a way of increasing development of innovative and clinically effective new medicines.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Reduces access to end product due to monopoly pricing. (Duerden, 2010)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Significant difficulties have been proposed when trying to apply patent term extensions to one class of drug only, without influencing other areas of R&amp;D. </span><a href="http://content.healthaffairs.org/content/29/9/1689.long"><span style="font-family:'Times New Roman'; font-size:11pt">(Kesselheim, 2010).</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">A significant potential confounding factor in establishing the affordability of new pricing procedures is the current market share of generics in the UK. Specifically for ‘infections’ medicine, the market share of generics is over 90%. Current expenditure on ‘infections’ pharmaceuticals is £273 million; this will rise significantly as new patented medicines are introduced. (Hawe, 2013)</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr><tr><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Expedited Regulatory Review</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Speeds up review process offering companies faster access to market</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Reduces the cost of regulatory processes, making overall </span><span style="font-family:'Times New Roman'; font-size:11pt">R&amp;D cheaper.</span></p></td><td style="background-color:#dd7e6b; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Can result in poorer quality/evidenced medicines. In particular applications a) do not always provide a comprehensive toxicity profile b) were inappropriately compared to placebo when better treatment was available c) used very small sample groups d) relied too much on surrogate end-points e) were of inadequate trial length f) were for pre-</span><span style="font-family:'Times New Roman'; font-size:11pt">existing drugs g) </span><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="font-family:'Times New Roman'; font-size:11pt">when receiving conditional approval were not followed by appropriate review.</span><span style="font-family:'Times New Roman'; font-size:11pt"> (Joppi et al. 2010)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Ineffective at stimulating R&amp;D for orphan drugs (63 products in ten years), for the majority of the 7,000 rare or orphan diseases, effective treatments have not been developed</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span><a href="http://link.springer.com/article/10.1007%2Fs00228-012-1423-2#page-1"><span style="font-family:'Times New Roman'; font-size:11pt">(Joppi et al, 2010)</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Effects limited to a few specific classes of drugs as “</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">orphan drug research investments in lucrative fields, such as oncology, to the detriment of other previously unaddressed or under-addressed rare diseases</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">”</span><span style="font-family:'Times New Roman'; font-size:11pt">. (Wellman-Labadie, 2010).</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Price Adjustments / Reimbursement</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">NICE, has significant expertise in conducting cost-benefit analyses. </span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">A Value-Based Pricing Scheme is due to come into effect in 2014, modifying this to reward antibiotics wouldn’t be too difficult.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Raising the cost of the drug, would also reduce excessive consumption or prescription. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Value-based pricing could provide clear and transparent priorities, set by relevant stakeholders, to the pharmaceutical industry. </span></p><p style="margin:0pt; text-align:justify"><br /><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.75pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.75pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding:5.25pt; vertical-align:top"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Calculating the cost of drugs R&amp;D costs is a difficult procedure, made even more difficult by a lack of transparency. Currently, drug R&amp;D costs are inflated at best, if not outright manipulated, with the true cost estimated to be around $60 million, rather than the industry supported $1.3billion figure.</span><span style="font-family:'Times New Roman'; font-size:11pt"> (Light, 2011) (Light, 2012).</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">There is a lack of evidence on VBP, although it has been trialled in Sweden to no ill effect. </span><a href="http://ukpolicymatters.thelancet.com/value-based-pricing/"><span style="color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">(Latif, 2013)</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">As long as negotiations are “confidential between the authorities and pharmaceutical companies, there is considerable scope for incentives, rewards and favouritism”. </span><a href="http://www.eco.uc3m.es/servicios/sesam/actividades/jornada_legislacion/DOC%209%20EMEARoadMap.pdf"><span style="color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">(Kavanos, 2001)</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> This jeopardises the chances of optimal price setting.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The pharmaceutical industry is free to set the price of any given drug. This could provide a financial incentive for pharmaceutical companies to ‘game the system’ as they have a direct interest in securing the highest price possible.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">The setting of price thresholds for new drugs is effectively setting the priorities for what we as a society want. Poor threshold setting could </span><span style="font-family:'Times New Roman'; font-size:11pt">result in marginalization of certain groups of society through either a lack of drugs, or the presence of prohibitively expensive ones.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td></tr></table><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></div><br style="clear:both; mso-break-type:section-break; page-break-before:always" /><div><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">Bibliography</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Abrams, D (2009) Did TRIPs spur innovation? An analysis of patent duration and incentives to innovate. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">University of Pennsylvania Law Review</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 157, 1613-1647</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Davies, S et al (2001) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Annual Report of the Chief Medical Officer, Volume Two; Infections and the rise of antimicrobial resistance</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. Department of Health. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Anon. (2012) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">New drugs and indications in 2011: France is better focused on patients’ interests after the Mediator scandal, but stagnation elsewhere. Prescrire Int.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 21, 107-10. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Braine T. (2011) Race against time to develop new antibiotics. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Bull World Health Organ</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 89, 88–9. </span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">CDC. (2013). </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Threat Report 2013: </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Antimicrobial Resistance.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> CDC [online] Available at: http://www.cdc.gov/drugresistance/threat-report-2013/ [Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Cosgrove S (2006). The relationship between antimicrobial resistance and patient outcomes: </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">mortality, length of stay, and health care costs. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Clinical Infectious Diseases</span><span style="font-family:'Times New Roman'; font-size:11pt">, 42, 82–89.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Cosgrove S, Carmeli S (2003). The impact of antimicrobial resistance on health and economic </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">outcomes. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Clinical Infectious Diseases</span><span style="font-family:'Times New Roman'; font-size:11pt">, 36, 1433–1437.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Department of health. (2013) </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">UK Five Year Antimicrobial Resistance Strategy, 2013 to 2018</span><span style="font-family:'Times New Roman'; font-size:11pt">. London, Department of Health. [online] Available at: </span><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf"><span style="color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> [Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Department of health. (2010) </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">A new value-based approach to the pricing of medicines</span><span style="font-family:'Times New Roman'; font-size:11pt"> London, Department of Health. [online] Available at: </span><a href="http://www.dhsspsni.gov.uk/medicineconsultation.pdf"><span style="color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.dhsspsni.gov.uk/medicineconsultation.pdf</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> [Accessed 4 Nov 2013]</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Duerden, M; Hughes, D (2010) Generic and therapeutic substitutions in the UK: are they a good thing? </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Br J Clin Pharmacol</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 70(3), 335–341.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">European Commission (2011) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">EU Action plan against the rising threats from Antimicrobial Resistance</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, European Commission [online] Available from:</span></p><p style="margin:0pt; text-align:justify"><a href="http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">European Academies Science Advisory Council (2007). </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Tackling antibiotic resistance in Europe.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">London, The Royal Society [online] Available from: </span><a href="http://www.knaw.nl/pdf/EASAC_Antibacterial_resistance.pd"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.knaw.nl/pdf/EASAC_Antibacterial_resistance.p</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">df [Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">European Medicines Agency, European Centre for Disease Prevention and Control. (2009) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Joint technical report: the bacterial challenge—time to react.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> ECDC. [online] Available from: </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><a href="http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Generic Pharmaceutical Association (2011) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Savings: an economic analysis of generic drug usage in the US. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[online] Available from: </span><a href="http://www.tevagenerics.com/assets/base/pdf/Savings,AnEconomicAnalysis.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.tevagenerics.com/assets/base/pdf/Savings,AnEconomicAnalysis.pdf</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Grace, C (2010) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Product Development Partnerships (PDPs): Lessons from PDPs established to develop new health technologies for neglected diseases.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> London, DfID [online] Available from: </span><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/67678/lssns-pdps-estb-dev-new-hlth-tech-negl-diseases.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/67678/lssns-pdps-estb-dev-new-hlth-tech-negl-diseases.pdf</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Hawe, E; Cockcroft, L. (2013) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">OHE Guide to UK Health and healthcare statistics. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[online] Office of Health Economics. Available from: </span><a href="http://www.ohe.org/publications/article/ohe-guide-to-uk-health-and-health-care-statistics-135.cfm"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.ohe.org/publications/article/ohe-guide-to-uk-health-and-health-care-statistics-135.cfm</span></a></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Joppi, R; Bertele’, V; Garattini, Silvio (2013) Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Eur J Clin Pharmacology</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 69, 1009-1024</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 8pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Juliano RL. (2013) Pharmaceutical innovation and public policy: the case for a new strategy for drug discovery and development. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Science and Public Policy</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 40(3), 393-405</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Kavanos, P (2001) Overview of pharmaceutical pricing and reimbursement regulation. [online] </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">London School of Economics </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Available from: </span><a href="http://www.eco.uc3m.es/servicios/sesam/actividades/jornada_legislacion/DOC%209%20EMEARoadMap.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.eco.uc3m.es/servicios/sesam/actividades/jornada_legislacion/DOC%209%20EMEARoadMap.pdf</span></a></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Kesselheim, A; Outerson, K (2010) Fighting antibiotic resistance: marrying new financial incentives to meet public health goals. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Health Affairs</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">. 29(9), 1689-1696</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Kidell-Monroe, R., Helene Iversen, J. and Gopinathan, U. (2013). Medical R&amp;D Convention Derailed: Implications for the Global Health System.</span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic"> Journal of Health Diplomacy</span><span style="font-family:'Times New Roman'; font-size:11pt">, Available at: http://www.hsph.harvard.edu/global-health-and-population/files/2013/06/Medical-R-and-D-Convention-Derailed-Implications-For-The-Global-Health-System-3.pdf [Accessed: 5th Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Latif, A. (2013) Value-Based Pricing. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">The Lancet UK Policy Matters </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[online] Available from: </span><a href="http://ukpolicymatters.thelancet.com/value-based-pricing/"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://ukpolicymatters.thelancet.com/value-based-pricing/</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Light, D; Lexchin, J (2012) Pharmaceutical research and innovation: what do we get for all the money? </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">BMJ </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">345(4348)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Light, D; Warburton, R (2011) Demythologizing the high costs of pharmaceutical research </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">BioSocieties</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, 6</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-weight:bold">,</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 34–50</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Love, J. (2013). </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">WHO negotiators propose putting off R&amp;D treaty discussions until 2016 | Knowledge Ecology International. [online]</span><span style="font-family:'Times New Roman'; font-size:11pt"> Available at: http://keionline.org/node/1612 [Accessed: 5 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Mauldin P et al. (2010). Attributable hospital cost and length of stay associated with healthcare- associated </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">infections caused by antibiotic-resistant Gram-negative bacteria. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Antimicrobial Agents and Chemotherapy, </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">54, 109-115.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Moran, M .(2005) A Breakthrough in R&amp;D for Neglected Diseases: New Ways to Get the Drugs We Need. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">PLoS Med</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 2(9)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">NIHR. (2013). </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">NIHR’s Antimicrobial Resistance Themed Call.</span><span style="font-family:'Times New Roman'; font-size:11pt"> [online]Available from: </span><a href="http://www.themedcalls.nihr.ac.uk/amr/home"><span style="color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.themedcalls.nihr.ac.uk/amr/home</span></a><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> [Accessed: 4 Nov 2013]</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Okeke, I.N. et al. (2005). Antimicrobial resistance in developing countries. Part I: recent trends </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">and current status. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Lancet Infectious Diseases</span><span style="font-family:'Times New Roman'; font-size:11pt">, 5, 481–493.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Olson, M. (2008) The Risk We Bear: The Effects of Review Speed and User Fee Funding on</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">New Drug Safety. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Journal of Health Economics</span><span style="font-family:'Times New Roman'; font-size:11pt"> 27, 175–200.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="font-family:'Times New Roman'; font-size:11pt">Roberts, R. et al. (2009). Hospital and societal costs of antimicrobial-resistance infections in </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">a Chicago teaching hospital: implications for antibiotic stewardship. </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Clinical Infectious </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Diseases</span><span style="font-family:'Times New Roman'; font-size:11pt">, 49, 1175–1184.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Scannell, J.W., Blanckley A, Boldon H, et al. (2012) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Diagnosing the decline in pharmaceutical R&amp;D efficiency. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Nat Rev Drug Discov</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, 11, 191–200.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Simoens, S. (2011) Pricing and reimbursement of orphan drugs: the need for more transparency.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Orphanet Journal of Rare Diseases</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, 6,42 </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Smith, R.D. et al. (2005). Assessing the macroeconomic impact of a healthcare problem: the </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">application of computable general equilibrium analysis to antimicrobial resistance. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Journal of </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Health Economics</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, 24, 1055–1075.</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Spellberg, B., Powers J, Brass E, Miller L, Edwards J. (2004) Trends in antimicrobial drug development: implications for the future. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Clin Infect Dis</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 38, 1279-86.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Spellman, B. et al (2004) Trends in antimicrobial development: implications for the future. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Clinical Infectious Diseases.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 38, 1279-1286</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Aronsson, B., Boscan, I.S., Cars, O., Giamarellou, H., Gyssens, I.C., et al. (2009)</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">The bacterial challenge: time to react.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> European Centre for Disease Prevention and Control and European Medicines Agency joint report. [online] Available from: </span><a href="http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Tiime_to_React.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Tiime_to_React.pdf</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[Accessed: 4 Nov 2013].</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Tillotson, G. (2012) GAIN Act legislation: is it enough? </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">The Lancet infectious diseases.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 12, 823-824</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Vicente, M. et al. (2006). The fallacies of hope: will we discover new antibiotics to combat </span></p><p style="margin:0pt; text-align:justify"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">pathogenic bacteria in time?</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic"> FEMS Microbiology Reviews,</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> 30, 841–852.</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">Wellman-Labadie, O; Zhou, Y (2010) The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity? </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Health Policy</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">, 95, 216-228</span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">WHO. (2010). </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Policies and incentives for promoting innovation in antibiotic research.</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> [online] Available from: </span><a href="http://www.euro.who.int/__data/assets/pdf_file/0011/120143/E94241.pdf"><span style="background-color:#ffffff; color:#1155cc; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://www.euro.who.int/__data/assets/pdf_file/0011/120143/E94241.pdf</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> [Accessed: 4 Nov 2013] </span></p><p style="margin:0pt; text-align:justify"><br /><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">WHO (2012) </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt; font-style:italic">Research and development to meet health needs in developing countries: strengthening global financing and coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[online] Geneva: WHO. Available from: </span><a href="http://www.who.int/phi/CEWG_Report_5_April_2012.pdf"><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">http://www.who.int/phi/CEWG_Report_5_Apr​il_2012.pdf</span></a><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt"> </span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">&#xa0;</span><span style="background-color:#ffffff; font-family:'Times New Roman'; font-size:11pt">[Accessed: 4 Nov 2013] </span></p><p style="font-size:11pt; line-height:108%; margin:0pt 0pt 8pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>